RE:RE:Low Share Price Because...hmmmmmmm...Don't you wish we'd had a real shareholder activist a few months ago? I did.
Won't go any lower than this unless intentionally done. In any business you can analyze what the liquidation (scrap) value is. In this case it's a confirmatory 3b trial that's exceeding expectations with 61 of the interim (90 patients) done and the FDA giving fast track status. Anybody that's even remotely connected to the biosciences would tell you a measly $350 million ($1 per share) or even a measly $700 million ($2 per share) CANADIAN for a product for the US market at this stage of development is a no brainer. Baxter hasn't picked it off as they have an existing arrangement. No one else would do it as they know no sale possible at those prices. But on a liquidation basis wouldn't last five minutes at those prices. As MM points out even Paradigm says it's grossly undervalued. If you do own any shares...do you?...fear not as it's worth a couple of bucks anyway on liquidation. More if the SAMI DIMI interest is saleable.
You do capture it perfectly with your...Real management would have respected...shareholders...instead of seeing it as an opportunity to pillage.
I don't think you're alone in that thinking. In fact I'm 44% sure about it which is really almost 100% if you exclude control block insiders.